Page 2 - National Committee On Adverse Events Following Immunisation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from National committee on adverse events following immunisation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In National Committee On Adverse Events Following Immunisation Today - Breaking & Trending Today

'Shots limited, easing eligibility criteria now will be dangerous'

‘Shots limited, easing eligibility criteria now will be dangerous’
SECTIONS
Last Updated: Apr 11, 2021, 12:32 PM IST
Share
Synopsis
Current estimates show that till July-August, there will be just sufficient vaccines for the 40-crore people above the age of 45 years in the country, accounting for about a third of the population.
(This story originally appeared in
on Apr 11, 2021)NEW DELHI: India is operating amid a raging pandemic with finite supplies of vaccines and the primary role of vaccination is to reduce deaths and hospitalisation and opening the shots for the general population will be a gamble with lives, says Dr N K Arora, member of the National Committee on Adverse Events Following Immunisation (AEFI). ....

National Committee On Adverse Events Following Immunisation , Indian Council Of Medical Research , Operations Research Group , National Committee , Adverse Events Following Immunisation , Indian Council , Medical Research , Asymptomatic Infection , இந்தியன் சபை ஆஃப் மருத்துவ ஆராய்ச்சி , செயல்பாடுகள் ஆராய்ச்சி குழு , தேசிய குழு , இந்தியன் சபை , மருத்துவ ஆராய்ச்சி , தடுப்பு மருந்துகள் ,

Allaying concerns - The Hindu

Public trust is a key ingredient to successful vaccination programmes ....

European Medicines Agency , Bloomberg Vaccine Tracker , Allaying Concerns , Public Trust , Key Ingredient , Successful Vaccination Programmes , Million Doses Of Vaccine , Blood Clots , Temporary Halt To Vaccination Programmes , Astrazeneca Az Vaccine , No Causal Link Between Vaccines And The Occurrence Of Such Clots , General Population , Studies Based On The Us Population , Ongoing Vaccination Drives , Moderna Vaccines , Emergency Use Authorisations , Slight Increase In Untoward Complications , Az Trials In The United Kingdom , Approval In India , Transparency And Prompt Data Sharing , Building Public Trust , National Committee On Adverse Events Following Immunisation , Us Centers For Disease Control And Prevention , ப்ளூம்பெர்க் தடுப்பூசி டிராக்கர் , பொது நம்பிக்கை , விசை மூலப்பொருள் ,

Allaying concerns: The Hindu Editorial on public trust and vaccination programmes

Public trust is a key ingredient to successful vaccination programmes
A little over 392 million doses of vaccine have been administered globally, according to the Bloomberg Vaccine Tracker, with India accounting for around 9% of them. In the last week, there have been a flurry of reports from Europe, of blood clots developing in a very small fraction of those vaccinated and leading to a cascade of European countries announcing a temporary halt to their vaccination programmes involving the AstraZeneca (AZ) vaccine. WHO and the European Medicines Agency have underlined that there is no causal link between vaccines and the occurrence of such clots. In fact, there are less than 40 such occurrences reported so far, and that is much below the background of about 1,000 to 2,000 blood clots every single day in the general population, say studies based on the U.S. population. These organisations advocate that the ongoing vaccination drives continue, even accelerate, as the rate of vac ....

United Kingdom , Us Centers For Disease , National Committee On Adverse Events Following Immunisation , European Medicines Agency , Bloomberg Vaccine Tracker , National Committee , Adverse Events Following Immunisation , Disease Control , Allaying Concerns , Public Trust , Key Ingredient , Successful Vaccination Programmes , Million Doses Of Vaccine , Blood Clots , Temporary Halt To Vaccination Programmes , Astrazeneca Az Vaccine , No Causal Link Between Vaccines And The Occurrence Of Such Clots , General Population , Studies Based On The Us Population , Ongoing Vaccination Drives , Moderna Vaccines , Emergency Use Authorisations , Slight Increase In Untoward Complications , Az Trials In The United Kingdom , Approval In India , Transparency And Prompt Data Sharing ,